NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 165 filers reported holding NOVOCURE LTD in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $8,938,000 | +48.4% | 141,352 | +13.0% | 0.55% | +47.1% |
| Q1 2019 | $6,024,000 | +39.6% | 125,061 | -3.0% | 0.38% | +41.9% |
| Q4 2018 | $4,316,000 | -39.5% | 128,919 | -5.3% | 0.26% | -20.4% |
| Q3 2018 | $7,130,000 | -25.7% | 136,075 | -55.6% | 0.33% | -26.2% |
| Q2 2018 | $9,599,000 | +8.3% | 306,681 | -24.5% | 0.45% | +3.7% |
| Q1 2018 | $8,861,000 | -4.9% | 406,469 | -11.9% | 0.44% | +6.1% |
| Q4 2017 | $9,317,000 | +82.3% | 461,248 | +79.1% | 0.41% | +95.2% |
| Q3 2017 | $5,112,000 | – | 257,520 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |